Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Aug 25;5:PO.21.00122. doi: 10.1200/PO.21.00122

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 by American Society of Clinical Oncology

Creative Commons Attribution Non-Commercial No Derivatives 4.0 License: http://creativecommons.org/licenses/by-nc-nd/4.0/

PMC Copyright notice

FIG A3. — Cohort selection and treatment patterns for patients with METex14-altered NSCLC available for assessment in the CGDB: (A) cohort eligibility diagram and (B) treatment patterns diagram. ^aOf patients who received therapy postspecimen collection, 37 of 42 METi-treated, 24 of 75 platinum chemotreated, and 40 of 70 IO-treated patients began therapy post-CGP report receipt. CGDB, clinicogenomic database; CGP, comprehensive genomic profiling; FMI, Foundation Medicine; IO, immunotherapy; METi, MET inhibitors; NSCLC, non–small-cell lung cancer.